comprehensive -WSS

comprehensive

author：knowledge 2025-09-07 04:13:58 - browse：23

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Inaction leaves children at risk from dangerous chemotherapy drug

WSS

Prior authorization reform is both possible and imperative

FDA scientists endorse Pfizer/BioNTech Covid

What causes osteoarthritis? Researchers study link to brain protein

Medicare drug price lawsuits could be good politics for Biden

HPV vaccine, cervical cancer study delivers historic results

FDA approves Sage Therapeutics’ rapid

focus

comprehensive

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Heart disease in astronauts blamed on cosmic radiation

Supreme Court strikes down use of affirmative action

FDA approves Sage Therapeutics’ rapid

Dobbs anniversary: the lost opportunity of abortion as health care

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Malaria cases in Florida and Texas: Here’s what you need to know

The a glaring gap in research on serious mental illness and primary care

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Flint parents haunted by uncertainty, fears of lead poisoning

focus

Mass General, Mayo Clinic look to monetize custom

There's an unseen cost to disruptive road

Microsoft launches AI tool for clinical documentation through Epic

Pharma showers House GOP doctor with campaign cash

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Flint parents haunted by uncertainty, fears of lead poisoning

explore

Wikipedia

hotspot

entertainment